Abstract:The recurrent pathogenic variant KCNC1-p.Ala421Val (A421V) is a cause of developmental and epileptic encephalopathy characterized by moderate-to-severe developmental delay/intellectual disability, and infantile-onset treatment-resistant epilepsy with multiple seizure types including myoclonic seizures. Yet, the mechanistic basis of disease is unclear. KCNC1 encodes Kv3.1, a voltage-gated potassium channel subunit that is highly and selectively expressed in neurons capable of generating action potentials at high frequency, including parvalbumin-positive fast-spiking GABAergic inhibitory interneurons in cerebral cortex (PV-INs) known to be important for cognitive function and plasticity as well as control of network excitation to prevent seizures. In this study, we generate a novel transgenic mouse model with conditional expression of the Ala421Val pathogenic missense variant (Kcnc1-A421V/+ mice) to explore the physiological mechanisms of KCNC1 developmental and epileptic encephalopathy. Our results indicate that global heterozygous expression of the A421V variant leads to epilepsy and premature lethality. We observe decreased PV-IN cell surface expression of Kv3.1 via immunohistochemistry, decreased voltage-gated potassium current density in PV-INs using outside-out nucleated macropatch recordings in brain slice, and profound impairments in the intrinsic excitability of cerebral cortex PV-INs but not excitatory neurons in current-clamp electrophysiology. In vivo two-photon calcium imaging revealed hypersynchronous discharges correlated with brief paroxysmal movements, subsequently shown to be myoclonic seizures on electroencephalography. We found alterations in PV-IN-mediated inhibitory neurotransmission in young adult but not juvenile Kcnc1-A421V/+ mice relative to wild-type controls. Together, these results establish the impact of the recurrent Kv3.1-A421V variant on neuronal excitability and synaptic physiology across development to drive network dysfunction underlying KCNC1 epileptic encephalopathy.

KCNG4 genetic variant linked to migraine prevents expression of KCNB1

KCNG4 Genetic Variant Linked to Migraine Prevents Expression of KCNB1

Functional properties of a disease mutation for migraine in Kv2.1/6.4 channels

Functional Analysis of A Migraine-Associated Tresk K+ Channel Mutation

Migraine-Associated TRESK Mutations Increase Neuronal Excitability through Alternative Translation Initiation and Inhibition of TREK

A novel loss-of-function KCNB1 gene variant in a twin with global developmental delay and seizures

Genome-wide association study of migraine implicates a common susceptibility variant on 8q22. 1

Linking a genetic defect in migraine to spreading depression in a computational model

Identification of Polymorphisms in EAAT1 Glutamate Transporter Gene SLC1A3 Associated with Reduced Migraine Risk

Evaluation of four KCNMA1 channelopathy variants on BK channel current under CaV1.2 activation

Common variants in KCNK5 and FHL5 genes contributed to the susceptibility of migraine without aura in Han Chinese population

Defective Membrane Expression Of The Na+-Hco3- Cotransporter Nbce1 Is Associated With Familial Migraine

A high-density association screen of 155 ion transport genes for involvement with common migraine

Non-vascular ATP-sensitive potassium channel activation does not trigger migraine attacks: A randomized clinical trial

Electrophysiological characterization of a CaV3.1 calcium channel mutation linked to trigeminal neuralgia

A KCNC1 Variant Linked to Rett Syndrome Disrupts ER to Golgi Trafficking of Kv3.1 Channel

Voltage-gated calcium channels as potential therapeutic targets in migraine

Functional regulation of Kv4.3 by 157T and V65M, two kinds of LQT6 associated mutations in KCNE2

Impaired excitability of fast-spiking neurons in a novel mouse model of KCNC1 epileptic encephalopathy

A novel autism-associated KCNB1 mutation dramatically slows Kv2.1 potassium channel activation, deactivation and inactivation

Protein kinase Cδ as a neuronal mechanism for headache in a chronic intermittent nitroglycerin model of migraine in mice